Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)
Class III · Ongoing
Failed Impurities/Degradations Specifications
Advertisement
Advertisement
Affected lots / codes — check yours against thisBatch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027.
- Recalling firm
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Classification
- Class III (unlikely to cause harm)
- Status
- Ongoing
- Quantity
- 898,050 vials
- Distribution
- US Nationwide.
- Recall initiated
- May 14, 2026
- Classified
- June 5, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0581-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0581-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →